Page last updated: 2024-10-28

n-(2-aminoethyl)-5-isoquinolinesulfonamide and Adrenocortical Carcinoma

n-(2-aminoethyl)-5-isoquinolinesulfonamide has been researched along with Adrenocortical Carcinoma in 1 studies

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ma, C1
Xiong, J1
Su, H1
Li, H1

Other Studies

1 other study available for n-(2-aminoethyl)-5-isoquinolinesulfonamide and Adrenocortical Carcinoma

ArticleYear
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
    International journal of medical sciences, 2021, Volume: 18, Issue:13

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Biomarkers

2021